Viewing nowCombinationDucarb Tablet 60/10 mg
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.

MFDS item code 201603072 · Approved 2016.05.30 · Insurance code 641906470
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with pimasartan potassium. It helps to effectively manage blood pressure and reduce the risk of cardiovascular complications. Therefore, this medication plays an important role in the treatment of hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment with the fimasartan 30 mg component of this medicine should be initiated. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used in certain patients. For example, those who are allergic to this medication's ingredients, pregnant or breastfeeding, undergoing kidney dialysis, have severely impaired liver function, have bile duct obstruction, have certain types of diabetes, have severe aortic stenosis, or are in shock should not take it as it may be dangerous. Patients with low blood volume or reduced salt, impaired kidney function, renal vascular hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and those with allergies to certain dyes should take special caution when using this medication. Side effects such as dizziness, headache, swelling, urination difficulty, insomnia, and flushing may occur while taking this medication, and serious adverse reactions may occur rarely; thus, it is crucial to consult a healthcare professional if symptoms arise. This medication lowers blood pressure, so care must be taken as dizziness or fainting can occur if blood pressure drops too low when starting or increasing the dosage. Furthermore, this medication can increase potassium levels in the blood; patients with heart or kidney diseases should have regular blood tests. Interactions may occur when using this medication with other blood pressure medications, diuretics, and potassium-sparing drugs, so patients should inform healthcare providers of any other medications they are taking. It may be risky for the fetus during pregnancy, so it should not be taken if planning to become pregnant or during pregnancy, and breastfeeding should be avoided or discontinued. Safety and efficacy have not been established for use in children under 18. Elderly patients may also respond more sensitively to this medication, so caution is needed during use. This medication should not be used in patients with severely impaired liver function. In case of overdose, blood pressure may drop too low and heart rhythm may become irregular, so if accidental overdose is suspected, a healthcare professional should be contacted immediately. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not transmit light. Additionally, it is important to maintain a room temperature of 1 to 30 degrees Celsius when storing the medication. This way, the effectiveness of the medication will not decrease, and it can be used safely.
Orange apple-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.